Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Future Microbiol ; 18: 1025-1039, 2023 11.
Article in English | MEDLINE | ID: mdl-37540066

ABSTRACT

Aim: Our study evaluated the activity of sertraline (SER) alone and associated with antifungal drugs in planktonic Candida spp. strains, and investigated its mechanism of action. Materials & methods: Broth microdilution method and minimum fungicidal concentration/MIC ratio were used to assess SER anticandidal activity, and the interaction with antifungals was determined by fractional inhibitory concentration index. The mechanism of action was investigated by flow cytometry and in silico tests. Results: SER inhibited Candida spp. strains at low concentrations by the fungicidal effect and showed no loss of effectiveness when combined. Its action seemed to be related to the membrane and cell wall biosynthesis inhibition. Conclusion: SER has activity against Candida spp. isolated and associated with antifungals, and acts by causing cell wall and membrane damage.


Subject(s)
Antifungal Agents , Candida , Antifungal Agents/pharmacology , Sertraline/pharmacology , Cell Wall , Microbial Sensitivity Tests
2.
Future Microbiol ; 18: 505-519, 2023 05.
Article in English | MEDLINE | ID: mdl-37204289

ABSTRACT

Aim: This study was designed to evaluate the in vitro antimicrobial activity of amlodipine against Staphylococcus aureus strains. Materials & methods: The antimicrobial activity of amlodipine was evaluated by the broth microdilution method and its interaction with oxacillin was evaluated by checkerboard assay. The possible mechanism of action was evaluated by flow cytometry and molecular docking techniques. Results: Amlodipine showed activity against S. aureus between 64 and 128 µg/ml, in addition to showing synergism in approximately 58% of the strains used. Amlodipine also showed good activity against forming and mature biofilms. The possible mechanism of action may be attributed to its ability to lead to cell death. Conclusion: Amlodipine has antibacterial activity against S. aureus.


Subject(s)
Methicillin-Resistant Staphylococcus aureus , Staphylococcal Infections , Humans , Oxacillin/pharmacology , Staphylococcus aureus , Amlodipine/pharmacology , Molecular Docking Simulation , Drug Synergism , Anti-Bacterial Agents/pharmacology , Staphylococcal Infections/drug therapy , Staphylococcal Infections/microbiology , Microbial Sensitivity Tests
3.
Future Microbiol ; 18: 415-426, 2023 May.
Article in English | MEDLINE | ID: mdl-37213136

ABSTRACT

Aim: To evaluate the antibacterial activity of paroxetine alone and associated with oxacillin against isolates of methicillin-sensitive and -resistant Staphylococcus aureus. Materials & methods: The broth microdilution and checkerboard techniques were used, with investigation of possible mechanisms of action through flow cytometry, fluorescence microscopy and molecular docking, in addition to scanning electron microscopy for morphological analysis. Results: Paroxetine showed a MIC of 64 µg/ml and bactericidal activity, mostly additive interactions in combination with oxacillin, evidence of action on genetic material and membrane, morphological changes in microbial cells and influence on virulence factors. Conclusion: Paroxetine has antibacterial potential from the perspective of drug repositioning.


Subject(s)
Methicillin-Resistant Staphylococcus aureus , Staphylococcal Infections , Humans , Staphylococcus aureus , Paroxetine/pharmacology , Molecular Docking Simulation , Anti-Bacterial Agents/pharmacology , Oxacillin/pharmacology , Staphylococcal Infections/drug therapy , Microbial Sensitivity Tests
4.
Future Microbiol ; 17: 1363-1379, 2022 Nov.
Article in English | MEDLINE | ID: mdl-36169348

ABSTRACT

Aims: This study aimed to evaluate the antibacterial effect of two new cationic surfactants based on phenylalanine-arginine (LPAM) and tryptophan-arginine (LTAM). Materials & methods: Antibacterial activity, mechanism of action and interactions with Staphylococcus aureus enzymes were measured through microbiological, flow cytometry and molecular docking assays, respectively. Results & conclusion: These compounds showed antibacterial activity in the range of 4.06-16.24 µg/ml against planktonic cells and no activity against mature biofilms, since they caused a loss of membrane integrity and increased DNA damage, as revealed by flow cytometry analysis. In silico assays revealed the existence of molecular bonds such as hydrogen bonds, mainly with DNA. Therefore, these compounds have promising pharmacological activity against MRSA strains.


Subject(s)
Methicillin-Resistant Staphylococcus aureus , Staphylococcal Infections , Humans , Staphylococcus aureus , Tryptophan/pharmacology , Microbial Sensitivity Tests , Arginine/pharmacology , Arginine/chemistry , Surface-Active Agents/pharmacology , Molecular Docking Simulation , Staphylococcal Infections/drug therapy , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/chemistry , Biofilms , Phenylalanine/pharmacology
5.
Future Microbiol ; 17: 607-620, 2022 05.
Article in English | MEDLINE | ID: mdl-35411812

ABSTRACT

Objective: The present study investigated the antifungal action of dexamethasone disodium phosphate (Dex). Methodology: Susceptibility testing was performed using the Clinical & Laboratory Standards Institute protocol; M27-A3, checkerboard test and biofilm were evaluated with two isolates of Candida albicans, hyphal production test, molecular docking analysis and flow cytometry analysis. Result: Dex and fluconazole (FLC) together had a synergistic effect. Mature biofilm was reduced when treated with Dex alone or in combination. Dex and FLC promoted a decrease in the production of hyphae and changes in the level of mitochondrial depolarization, increased generation of reactive oxygen species, loss of membrane integrity, increased phosphatidylserine externalization and molecular docking; there was interaction with ALS3 and SAP5 targets. Conclusion: Dex showed antifungal activity against FLC-resistant C. albicans strains.


This study aimed to evaluate the antifungal action of dexamethasone against FLC-resistant C. albicans strains.


Subject(s)
Candida albicans , Fluconazole , Antifungal Agents/pharmacology , Biofilms , Dexamethasone/pharmacology , Drug Resistance, Fungal , Drug Synergism , Fluconazole/pharmacology , Microbial Sensitivity Tests , Molecular Docking Simulation
6.
Future Microbiol ; 17: 437-448, 2022 04.
Article in English | MEDLINE | ID: mdl-35285249

ABSTRACT

Aims: To evaluate the antifungal effect of dobutamine against Candida glabrata as well as its synergism with azoles and its action on biofilm. Methods: The M27-A3 protocol and flow cytometry were used for elucidation of the possible mechanism of action. Results: The tested isolates presented MICs ranging from 2 to 32 µg/ml for dobutamine, with fungistatic effect. A total of 82% of the strains showed synergism with fluconazole, with 90% showing synergism with itraconazole. The effect on biofilm formation was nonsignificant. Cytometry tests showed that dobutamine induced mitochondrial depolarization. Conclusion: Dobutamine has an antifungal effect on strains of C. glabrata and synergistic activity with azoles. This effect is probably mediated by increased oxidative damage to the membrane.


Subject(s)
Azoles , Candida glabrata , Antifungal Agents/pharmacology , Azoles/pharmacology , Dobutamine/pharmacology , Drug Resistance, Fungal , Fluconazole/pharmacology , Microbial Sensitivity Tests
7.
Future Microbiol ; 17: 599-606, 2022 05.
Article in English | MEDLINE | ID: mdl-35354285

ABSTRACT

Aim: To evaluate the antifungal activity of gallic acid (GA) against the strains of Candida spp. resistant to fluconazole and to determine its mechanism of action. Materials & methods: Antifungal activity was evaluated using the broth microdilution and flow cytometry techniques. Results: GA presented minimum inhibitory concentrations ranging from 16 to 72 µg/ml, causing alterations of the membrane integrity and mitochondrial transmembrane potential, production of reactive oxygen species and externalization of phosphatidylserine. Conclusion: GA has potential antifungal activity against Candida spp.


Subject(s)
Antifungal Agents , Candida albicans , Antifungal Agents/pharmacology , Apoptosis , Cell Death , Drug Resistance, Fungal , Fluconazole/pharmacology , Gallic Acid/pharmacology , Microbial Sensitivity Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...